Sam Altman’s OpenAI: Balancing Mission and Market in the AI Power Play
OpenAI under Sam Altman exemplifies the tension between pioneering AI innovation and navigating the commercial and political power struggles shaping the industry’s future.
June 2026
Read More
Anthropic Launches Claude Tag to Embed AI Deeply into Enterprise Workflows via Slack
Anthropic introduces Claude Tag, an always-on AI assistant for Slack designed to capture organizational context and boost enterprise productivity while competing directly with OpenAI’s ChatGPT in the workplace.
Converge Bio Secures $25M Series A Led by Bessemer, Backed by Meta, OpenAI, and Wiz Executives
Converge Bio, an AI drug discovery startup, raised $25 million in a Series A round led by Bessemer Venture Partners, with additional investment from executives at Meta, OpenAI, and Wiz, highlighting growing cross-sector interest in AI-powered biotech innovation.
OpenAI Launches Patch the Planet to Strengthen Open Source Security with AI and Expert Collaboration
OpenAI’s new Daybreak initiative, Patch the Planet, aims to empower open-source maintainers by leveraging AI and expert validation to identify and fix software vulnerabilities.
Computer Vision Drives Major Productivity Gains in Retail Sector
Computer vision deployments are transforming retail operations by automating shelf tracking, significantly reducing costly in-store execution failures and boosting productivity.
Microsoft’s Data Center Expansion Puts AI Ambitions at Odds with Sustainability Goals
Microsoft’s aggressive data center expansion to support AI services including OpenAI-powered ChatGPT strains its sustainability targets, highlighting tensions in the AI infrastructure race.
Sam Altman’s Dual Challenge: Navigating Power and Trust in the AI Era
Sam Altman’s rise highlights the tension between AI innovation, business interests, and public trust—shaping the future of AI governance and industry dynamics.
Google DeepMind Elevates Interactions API as Core Interface for Gemini Models
Google DeepMind has designated the Interactions API as the default interface for its Gemini AI models and agents, marking a strategic shift in how these systems handle interactions and features.
Converge Bio Raises $25M to Advance AI-Driven Drug Discovery with Backing from OpenAI and Meta Executives
Converge Bio, an AI-powered drug discovery startup, raised $25 million in a Series A round led by Bessemer, with additional investments from executives at OpenAI, Meta, and Wiz, signaling growing interest in AI applications beyond traditional tech giants.
Google DeepMind Invests $75M in AI-Driven Filmmaking Through Partnership with A24
Google DeepMind and indie film studio A24 are collaborating to develop AI tools for filmmaking, marking a $75 million investment into reshaping Hollywood’s creative processes.